Clinical Trial Update: PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update involving a PD-1 antibody combined with chidamide, lenalidomide, and gemcitabine for peripheral T-cell lymphoma is described, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Gemcitabine (Gemcitabine)
• Lenalidomide (lenalidomide)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Mingzhi Zhang | Conditions: Peripheral T-cell Lymphoma | Phase 4 | Status: UNKNOWN